Strata Critical Medical, Inc. (SRTA)
| Market Cap | 496.62M +23.6% |
| Revenue (ttm) | 280.76M +68.4% |
| Net Income | -24.81M |
| EPS | -0.29 |
| Shares Out | 89.32M |
| PE Ratio | n/a |
| Forward PE | 92.67 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,354,886 |
| Open | 5.23 |
| Previous Close | 5.26 |
| Day's Range | 5.16 - 5.62 |
| 52-Week Range | 3.95 - 6.50 |
| Beta | 2.56 |
| Analysts | Strong Buy |
| Price Target | 9.56 (+72.0%) |
| Earnings Date | Nov 3, 2026 |
About SRTA
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perf... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for SRTA stock is "Strong Buy." The 12-month stock price target is $9.56, which is an increase of 72.00% from the latest price.
News
Strata Critical Medical to Present at the UBS Global Healthcare Conference
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the UBS Global Healthcare Conferenc...
Strata Critical Medical Earnings Call Transcript: Q3 2026
Q3 revenue rose 50.3% YoY and Adjusted EBITDA reached $9.6 million, with record $8.6 million free cash flow. FY2026 guidance was reiterated; clinical growth and acquisitions underpin 2027 targets.
Strata Critical Medical Earnings release: Q3 2026
Strata Critical Medical released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
Strata Critical Medical Slides: Q3 2026
Strata Critical Medical has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
Strata Critical Medical Prepared remarks: Q3 2026
Strata Critical Medical filed a regulatory document on November 3, 2026 disclosing important business information.
Strata Critical Medical Quarterly report: Q3 2026
Strata Critical Medical has published its Q3 2026 quarterly earnings report on November 3, 2026.
Strata Critical Medical reports Q3 EPS (9c) vs. 70c last year
Reports Q3 revenue $74.08M, consensus $72.67M. “Our strong third quarter results speak for themselves,” said Melissa Tomkiel, Co-CEO and General Counsel. “We demonstrated additional market share gains...
Strata Critical Medical backs FY26 revenue view $285M-$295M, consensus $290.8M
Backs FY26 adjusted EBITDA view $33M-$35M. Heyburn continued, “We are also pleased to report that we are pacing ahead of the medium-term goals we set out last year. The underlying…
Strata Critical Medical Announces Third Quarter 2026 Results
Revenue increased 50.3% year-over-year to $74.1 million in Q3 2026 Clinical revenue increased 20.3% sequentially in Q3 2026 vs Q2 2026 Q3 2026 net loss from continuing operations of $(7.6) million or ...
Strata Critical Medical Schedules Third Quarter 2026 Earnings Conference Call
NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the third quarter ended September 30, 2026 on Tuesday...
Strata Critical Medical Transcript: 2026 Jefferies Healthcare Services and Technology Conference
Organ transplant logistics and clinical services are rapidly evolving due to regulatory and technological advances, with strong growth in Donation after Circulatory Death and perfusion services. The business leverages an asset-light, national platform and aggressive acquisition strategy to outpace industry growth and improve efficiency.
Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 2026 Jefferies Healthcare Serv...
Strata Critical Medical management to meet with Craig-Hallum
Meeting to be held in Minneapolis on August 11-12 hosted by Craig-Hallum.
Strata Critical Medical Earnings Call Transcript: Q2 2026
Q2 2026 saw strong clinical growth, improved cash flow, and strategic acquisitions, offset by a temporary logistics revenue dip due to a unique customer event. Guidance for 2026 was raised on both revenue and EBITDA, with clinical margins and business mix expected to improve further.
Strata Critical Medical Earnings release: Q2 2026
Strata Critical Medical released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Strata Critical Medical Slides: Q2 2026
Strata Critical Medical has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Strata Critical Medical Quarterly report: Q2 2026
Strata Critical Medical has published its Q2 2026 quarterly earnings report on August 4, 2026.
Strata Critical Medical Announces Second Quarter 2026 Results
Revenue increased 60.7% year-over-year to $72.5 million in Q2 2026 Clinical revenue increased 22.6% sequentially in Q2 2026; Excluding Clinical acquisitions that closed in Q2 2026, Clinical revenue in...
Strata Critical Medical Slides: Investor presentation
Strata Critical Medical has posted slides in relation to its latest quarterly earnings report, which was published on August 4, 2026.
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the second quarter ended July 31, 2026 on Tuesday, Au...
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
Network of experienced transplant surgeons in key markets will immediately become available to all Strata customers Adds significant scale to Transplant Clinical, Strata's fastest growing business lin...
Strata Critical Medical management to meet with B. Riley
Meeting to be held in Canada on June 22-23 hosted by B. Riley.
Strata Critical Medical Transcript: 16th Annual East Coast IDEAS Conference
The company has transformed into a leading, integrated transplant logistics and clinical services provider, achieving rapid organic growth and leveraging regulatory and technological trends to outpace industry expansion. Strong financials and a flexible, asset-light model support ongoing M&A and organic growth initiatives.
Strata Acquires Louisville Perfusion Services
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that it has completed the acquisition of Louisville Perfusion Servi...
Strata Critical Medical Transcript: AGM 2026
The meeting featured board leadership transitions, approval of all shareholder proposals—including director elections, auditor ratification, and executive compensation—and reaffirmed corporate governance practices. Stockholders were encouraged to participate in Q&A and future compensation decisions will reflect their input.